A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...
It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...
Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.
A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...
Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...
Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.
Avelox (moxifloxacin), Levaquin (levoflaxoacin), and Cipro (ciprofloxacin) are antibiotics in the class known as fluoroquinolones and are used to treat serious bacterial infections, including urinary tract, sinus, and ear infections. The drugs have also been tied to serious side effects … Continue reading →
Ciprofloxacin is a fluoroquinolone antibiotic that fights different types of bacterial infections, such as urinary tract or gastrointestinal infections. It is also used to treat people who have been exposed to anthrax. Ciprofloxacin should only be used for infections that … Continue reading →
The fluoroquinolone antibiotic Cipro (ciprofloxacin) is one the medications linked to the extreme allergic reaction Stevens-Johnson syndrome (SJS). Though Stevens-Johnson is not common, it can be fatal if not treated quickly, according to Top Class Actions.
Johnson & Johnson faces a new wave of lawsuits in federal court in New Jersey alleging its antibiotic Levaquin caused nerve damage. From August 1 to 11, 13 Levaquin suits with 18 plaintiffs were filed against Johnson & Johnson and … Continue reading →
According to a new report, antibiotics in the same class as Avelox (moxifloxacin) were the drugs most frequently associated with reports of persistent adverse effects in 2015. The report appeared in QuarterWatch, a publication of the Institute for Safe Medication … Continue reading →
Fluoroquinolones are a class of antibiotics that include ciprofloxacin (brand names: Cipro, Cetraxal and Proquin), levofloxacin (Levaquin, Quixin and Iquix), moxifloxacin (brand name: Avelox), gemifloxacin (brand name: Factive) and ofloxacin (brand name: Ofloxacin). One potential side effect that may occur … Continue reading →
In May 2016, the U.S. Food and Drug Administration (FDA) warned about the risks of fluoroquinolone antibiotics, which include Levaquin, Avelox and Cipro. The agency said that, given the risk of potentially permanent side effects, these medications should only be … Continue reading →
The U.S. Food and Drug Administration (FDA) has approved labeling changes on fluoroquinolone antibiotics, which include levofloxacin (Levaquin), ciprofloxacin (Cipro), ciprofloxacin extended-release tablets, moxifloxacin (Avelox), ofloxacin and gemifloxacin (Factive). In a news release issued Tuesday, the agency said the Boxed … Continue reading →
Hundreds of product liability lawsuits involving the fluoroquinolone antibiotics Levaquin, Cipro and Avelox are moving toward trial in a multidistrict litigation (MDL) in the U.S. District Court, District of Minnesota. In June 2016, the court granted a motion from the … Continue reading →
New studies have found that people taking fluoroquinolone antibiotics such as Cipro, Levaquin and Avelox are 2 to 3 times more susceptible to life-threatening damage to their aorta. The aorta is the body’s main artery that carries oxygenated blood from … Continue reading →